Selexys Pharmaceuticals

Develops drugs to treat inflammatory and thrombotic diseases

placeOklahoma City, Oklahoma, United States calendar_todayFounded 2002 groups7 employees language selexys.com

Innovation

5 patent families (5 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 773 times.

YearFilings
20121
20133
20142
20153
20162
20172
20182
20191

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon